Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 476-160-4
CAS number: 54807-34-0
An acute oral study has been performed on NaDMH. An acute oral and dermal study have been performed on the analogue substance DMH.
A dermal study was not carried out on NaDMH
instead a read-across study from the analogue substance DMH has been
included in this registration. The classification for DMH is as follows:
DMH is not classified by the oral or dermal route as DMH has a LD50 >
5000 mg/kg by the oral route and a LD50 > 20000 mg/kg by the dermal
NaDMH is not classified by the oral route as
the LD50 > 2500 mg/kg.
The conclusion is that NaDMH is not
classified by the oral or dermal route as the LD50 is considered to be >
2500 mg/kg for both routes.
As previously stated an acute oral and
dermal study have been performed on DMH (Dimethyl Hydantoin) and have
been used for read-across purposes. A summary of data for read-across of
NaDMH with DMH is given in Section 13.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Do not show this message again